The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Associations of sarcopenia with hematologic toxicity, treatment intensity, and healthcare utilization in patients with metastatic colorectal cancer.
 
Matthew Lei
Honoraria - Abbvie; AstraZeneca; Epizyme
Consulting or Advisory Role - Intervention Insights
 
Ryan David Nipp
No Relationships to Disclose
 
Erica Tavares
No Relationships to Disclose
 
Uvette Lou
No Relationships to Disclose
 
Erica Grasso
No Relationships to Disclose
 
Stephanie Y Mui
No Relationships to Disclose
 
Jan Peter Marquardt
No Relationships to Disclose
 
Till D. Best
No Relationships to Disclose
 
Emily E. Van Seventer
Employment - Blueprint Medicines
Stock and Other Ownership Interests - Blueprint Medicines
 
Anurag Saraf
No Relationships to Disclose
 
Ismail Tahir
No Relationships to Disclose
 
Nora K. Horick
Employment - Northwest Biotherapeutics (I)
Stock and Other Ownership Interests - Northwest Biotherapeutics (I)
Patents, Royalties, Other Intellectual Property - An immediate family member holds patents, has patents pending, and receives royalties from a technology relating to health or medicine. (I)
 
Florian J. Fintelmann
No Relationships to Disclose
 
Eric Roeland
Consulting or Advisory Role - AIM Specialty Health; Asahi Kasei; Astellas Pharma; BASF; Helsinn Therapeutics; HERON; Napo Pharmaceuticals; Oragenics; Oragenics; Pfizer/EMD Serono; Vector Oncology
Expert Testimony - Regents of the University of California